Is there a need for an alternative source of red blood cells for clinical transfusion and will gene‐edited pigs fulfil that need?
D.K.C.C. is a consultant to eGenesis Bio of Cambridge, MA, but the opinions expressed in this article are those of the authors, and do not necessarily reflect those of eGenesis. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Asim Alam (ORCID: https://orcid.org/0000-0002-8269-1620)
- David K.C. Cooper (ORCID: https://orcid.org/0000-0003-4149-5452)
- Akihiro Maenaka (ORCID: https://orcid.org/0000-0002-6216-4890)
Institutions
- Harvard University (US)
- University of Toronto (CA)
- North York General Hospital (CA)
- Massachusetts General Hospital (US)
- Canadian Blood Services (CA)
Publication Details
- Journal
- Vox Sanguinis
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1111/vox.13802
- Primary Topic
- Xenotransplantation and immune response
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services
- American Society of Nephrology
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases